In a mouse model of CTCL, transgenic STAT3 hyper-activation in T cells was linked to IL-17 and IL-22 expression and phenotypic features of CTCL (21, 64). This evidence concerns the gene IL17A and primary cutaneous T-cell non-Hodgkin lymphoma.